Pneumococcal Vaccine Market - Global Outlook and Forecast 2022-2028

Publisher Name :
Date: 13-Jan-2022
No. of pages: 76

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

This report contains market size and forecasts of Pneumococcal Vaccine in global, including the following market information:

Global Pneumococcal Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Pneumococcal Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)

Global top five Pneumococcal Vaccine companies in 2021 (%)

The global Pneumococcal Vaccine market was valued at 7408.6 million in 2021 and is projected to reach US$ 7972.1 million by 2028, at a CAGR of 1.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

PPSV 23 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pneumococcal Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pneumococcal Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Pneumococcal Vaccine Market Segment Percentages, by Type, 2021 (%)

- PPSV 23

- PCV 7/13

- PCV 10

Global Pneumococcal Vaccine Market, by End User, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Pneumococcal Vaccine Market Segment Percentages, by End User, 2021 (%)

- Child

- Adult

Global Pneumococcal Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Pneumococcal Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pneumococcal Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Pneumococcal Vaccine revenues share in global market, 2021 (%)

Key companies Pneumococcal Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)

Key companies Pneumococcal Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Pfizer

- GSK

- MSD

- Sanofipasteur

- CDIBP

Pneumococcal Vaccine Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Pneumococcal Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by End User
1.3 Global Pneumococcal Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pneumococcal Vaccine Overall Market Size
2.1 Global Pneumococcal Vaccine Market Size: 2021 VS 2028
2.2 Global Pneumococcal Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pneumococcal Vaccine Sales: 2017-2028
3 Company Landscape
3.1 Top Pneumococcal Vaccine Players in Global Market
3.2 Top Global Pneumococcal Vaccine Companies Ranked by Revenue
3.3 Global Pneumococcal Vaccine Revenue by Companies
3.4 Global Pneumococcal Vaccine Sales by Companies
3.5 Global Pneumococcal Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pneumococcal Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pneumococcal Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pneumococcal Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Pneumococcal Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Pneumococcal Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pneumococcal Vaccine Market Size Markets, 2021 & 2028
4.1.2 PPSV 23
4.1.3 PCV 7/13
4.1.4 PCV 10
4.2 By Type - Global Pneumococcal Vaccine Revenue & Forecasts
4.2.1 By Type - Global Pneumococcal Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Pneumococcal Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Pneumococcal Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Pneumococcal Vaccine Sales & Forecasts
4.3.1 By Type - Global Pneumococcal Vaccine Sales, 2017-2022
4.3.2 By Type - Global Pneumococcal Vaccine Sales, 2023-2028
4.3.3 By Type - Global Pneumococcal Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Pneumococcal Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By End User
5.1 Overview
5.1.1 By End User - Global Pneumococcal Vaccine Market Size, 2021 & 2028
5.1.2 Child
5.1.3 Adult
5.2 By End User - Global Pneumococcal Vaccine Revenue & Forecasts
5.2.1 By End User - Global Pneumococcal Vaccine Revenue, 2017-2022
5.2.2 By End User - Global Pneumococcal Vaccine Revenue, 2023-2028
5.2.3 By End User - Global Pneumococcal Vaccine Revenue Market Share, 2017-2028
5.3 By End User - Global Pneumococcal Vaccine Sales & Forecasts
5.3.1 By End User - Global Pneumococcal Vaccine Sales, 2017-2022
5.3.2 By End User - Global Pneumococcal Vaccine Sales, 2023-2028
5.3.3 By End User - Global Pneumococcal Vaccine Sales Market Share, 2017-2028
5.4 By End User - Global Pneumococcal Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Pneumococcal Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Pneumococcal Vaccine Revenue & Forecasts
6.2.1 By Region - Global Pneumococcal Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Pneumococcal Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Pneumococcal Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Pneumococcal Vaccine Sales & Forecasts
6.3.1 By Region - Global Pneumococcal Vaccine Sales, 2017-2022
6.3.2 By Region - Global Pneumococcal Vaccine Sales, 2023-2028
6.3.3 By Region - Global Pneumococcal Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Pneumococcal Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Pneumococcal Vaccine Sales, 2017-2028
6.4.3 US Pneumococcal Vaccine Market Size, 2017-2028
6.4.4 Canada Pneumococcal Vaccine Market Size, 2017-2028
6.4.5 Mexico Pneumococcal Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Pneumococcal Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Pneumococcal Vaccine Sales, 2017-2028
6.5.3 Germany Pneumococcal Vaccine Market Size, 2017-2028
6.5.4 France Pneumococcal Vaccine Market Size, 2017-2028
6.5.5 U.K. Pneumococcal Vaccine Market Size, 2017-2028
6.5.6 Italy Pneumococcal Vaccine Market Size, 2017-2028
6.5.7 Russia Pneumococcal Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Pneumococcal Vaccine Market Size, 2017-2028
6.5.9 Benelux Pneumococcal Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Pneumococcal Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Pneumococcal Vaccine Sales, 2017-2028
6.6.3 China Pneumococcal Vaccine Market Size, 2017-2028
6.6.4 Japan Pneumococcal Vaccine Market Size, 2017-2028
6.6.5 South Korea Pneumococcal Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Pneumococcal Vaccine Market Size, 2017-2028
6.6.7 India Pneumococcal Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Pneumococcal Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Pneumococcal Vaccine Sales, 2017-2028
6.7.3 Brazil Pneumococcal Vaccine Market Size, 2017-2028
6.7.4 Argentina Pneumococcal Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pneumococcal Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Pneumococcal Vaccine Sales, 2017-2028
6.8.3 Turkey Pneumococcal Vaccine Market Size, 2017-2028
6.8.4 Israel Pneumococcal Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Pneumococcal Vaccine Market Size, 2017-2028
6.8.6 UAE Pneumococcal Vaccine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Pneumococcal Vaccine Major Product Offerings
7.1.4 Pfizer Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Pneumococcal Vaccine Major Product Offerings
7.2.4 GSK Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 GSK Key News
7.3 MSD
7.3.1 MSD Corporate Summary
7.3.2 MSD Business Overview
7.3.3 MSD Pneumococcal Vaccine Major Product Offerings
7.3.4 MSD Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 MSD Key News
7.4 Sanofipasteur
7.4.1 Sanofipasteur Corporate Summary
7.4.2 Sanofipasteur Business Overview
7.4.3 Sanofipasteur Pneumococcal Vaccine Major Product Offerings
7.4.4 Sanofipasteur Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Sanofipasteur Key News
7.5 CDIBP
7.5.1 CDIBP Corporate Summary
7.5.2 CDIBP Business Overview
7.5.3 CDIBP Pneumococcal Vaccine Major Product Offerings
7.5.4 CDIBP Pneumococcal Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 CDIBP Key News
8 Global Pneumococcal Vaccine Production Capacity, Analysis
8.1 Global Pneumococcal Vaccine Production Capacity, 2017-2028
8.2 Pneumococcal Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pneumococcal Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pneumococcal Vaccine Supply Chain Analysis
10.1 Pneumococcal Vaccine Industry Value Chain
10.2 Pneumococcal Vaccine Upstream Market
10.3 Pneumococcal Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pneumococcal Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Pneumococcal Vaccine in Global Market
Table 2. Top Pneumococcal Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pneumococcal Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pneumococcal Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Pneumococcal Vaccine Sales by Companies, (K Doses), 2017-2022
Table 6. Global Pneumococcal Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pneumococcal Vaccine Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Pneumococcal Vaccine Product Type
Table 9. List of Global Tier 1 Pneumococcal Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pneumococcal Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Pneumococcal Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pneumococcal Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pneumococcal Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pneumococcal Vaccine Sales (K Doses), 2017-2022
Table 15. By Type - Global Pneumococcal Vaccine Sales (K Doses), 2023-2028
Table 16. By End User - Global Pneumococcal Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By End User - Global Pneumococcal Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By End User - Global Pneumococcal Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By End User - Global Pneumococcal Vaccine Sales (K Doses), 2017-2022
Table 20. By End User - Global Pneumococcal Vaccine Sales (K Doses), 2023-2028
Table 21. By Region - Global Pneumococcal Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pneumococcal Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pneumococcal Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pneumococcal Vaccine Sales (K Doses), 2017-2022
Table 25. By Region - Global Pneumococcal Vaccine Sales (K Doses), 2023-2028
Table 26. By Country - North America Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pneumococcal Vaccine Sales, (K Doses), 2017-2022
Table 29. By Country - North America Pneumococcal Vaccine Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pneumococcal Vaccine Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Pneumococcal Vaccine Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pneumococcal Vaccine Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Pneumococcal Vaccine Sales, (K Doses), 2023-2028
Table 38. By Country - South America Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pneumococcal Vaccine Sales, (K Doses), 2017-2022
Table 41. By Country - South America Pneumococcal Vaccine Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pneumococcal Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pneumococcal Vaccine Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Pneumococcal Vaccine Sales, (K Doses), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Pneumococcal Vaccine Product Offerings
Table 48. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. GSK Corporate Summary
Table 50. GSK Pneumococcal Vaccine Product Offerings
Table 51. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. MSD Corporate Summary
Table 53. MSD Pneumococcal Vaccine Product Offerings
Table 54. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. Sanofipasteur Corporate Summary
Table 56. Sanofipasteur Pneumococcal Vaccine Product Offerings
Table 57. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. CDIBP Corporate Summary
Table 59. CDIBP Pneumococcal Vaccine Product Offerings
Table 60. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Pneumococcal Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 62. Global Pneumococcal Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Pneumococcal Vaccine Production by Region, 2017-2022 (K Doses)
Table 64. Global Pneumococcal Vaccine Production by Region, 2023-2028 (K Doses)
Table 65. Pneumococcal Vaccine Market Opportunities & Trends in Global Market
Table 66. Pneumococcal Vaccine Market Drivers in Global Market
Table 67. Pneumococcal Vaccine Market Restraints in Global Market
Table 68. Pneumococcal Vaccine Raw Materials
Table 69. Pneumococcal Vaccine Raw Materials Suppliers in Global Market
Table 70. Typical Pneumococcal Vaccine Downstream
Table 71. Pneumococcal Vaccine Downstream Clients in Global Market
Table 72. Pneumococcal Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pneumococcal Vaccine Segment by Type
Figure 2. Pneumococcal Vaccine Segment by End User
Figure 3. Global Pneumococcal Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Pneumococcal Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pneumococcal Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Pneumococcal Vaccine Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Pneumococcal Vaccine Revenue in 2021
Figure 9. By Type - Global Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pneumococcal Vaccine Price (USD/Dose), 2017-2028
Figure 12. By End User - Global Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 13. By End User - Global Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 14. By End User - Global Pneumococcal Vaccine Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 19. US Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 33. China Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pneumococcal Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pneumococcal Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pneumococcal Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pneumococcal Vaccine Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Pneumococcal Vaccine by Region, 2020 VS 2027
Figure 50. Pneumococcal Vaccine Industry Value Chain
Figure 51. Marketing Channels
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs